Skip to main content
Erschienen in: BMC Pediatrics 1/2023

Open Access 01.12.2023 | Case Report

Diagnosis of neonatal neurofibromatosis type 1: a case report and review of the literature

verfasst von: Qiuying Zheng, Bei Xia, Xiaoli Zhao, Ruijie Wang, Fusui Xie, Nihui Pei, Hongwei Tao, Tingting Ding, Lei Liu

Erschienen in: BMC Pediatrics | Ausgabe 1/2023

Abstract

Background

Neurofibromatosis Type 1 (NF1) is a rare genetic disorder characterized with the development of multiple benign tumors on the nerves and skin.

Case presentation

This report described a neonatal case with a large mass observed on the left side of the maxillofacial and cervical region at birth. Meantime, multiple cafe-au-lait macules (CALMs) were seen on the trunk and both lower extremities.

Conclusions

In this case, the clinical features of the rare NF1 neonate are discussed along with its ultrasound findings.
Hinweise

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Abkürzungen
NF1
Neurofibromatosis Type 1
CALMs
Cafe-au-lait macules
CNS
Central nervous system
NIH
National Institutes of Health
PNF
Plexiform neurofibroma

Background

As an autosomal dominant disorder, Neurofibromatosis Type 1 (NF1) has a neonatal morbidity of around 1/3000 [1]. NF1 gene mutation is the direct cause of NF1.Located on chromosome 17q11.2, NF1 is a tumor suppressor gene that encodes a neurofibromin, involved in the transduction cascade of multiple signals such as Ras/RAF/MEK/ERK, Akt/mTOR and AC/cAMP, and associated with cell proliferation and differentiation [2]. Typical clinical manifestations of NF1 are cutaneous neurofibromas, cafe-au-lait macules (CALMs), freckles, and Lisch nodules (iris malformations). Some cases are characterized clinically by seizures, learning and cognitive impairments, autism spectrum disorders, vascular diseases, cardiac malformations, central nervous system (CNS) tumors, skeletal abnormalities and other syndromes [3]. Many patients are usually undiagnosed or miss the best treatment opportunity due to the lack of symptoms or late onset. Only 46% of patients without family history are diagnosed before age 2 [4]. Among them, neonatal cases are even rarer. This report discussed a neonatal case with a large mass on the maxillofacial and cervical region, as well as its ultrasound imaging features and clinical presentations.

Case presentation

A 4-day-old female infant with gestational age of 39 weeks was admitted to our hospital with a mass of progressive enlargement in the left maxillofacial region. The child was born naturally due to premature rupture of membranes, with the umbilical cord around the neck one loop, and no abnormality found in placenta and amniotic fluid. Apgar score at birth was 10 in 1 min, 5 and 10 min respectively. Physical examination after admission showed edema on the left facial region and left eyelid region, ectropion of the left eyelid, conjunctival congestion, and faint yellow secretion. The mass on the left side of the maxillofacial to cervical region was slightly tough, with low local skin temperature, average mobility and without rupture (Fig. 1). The number of CALMs seen on the trunk and both lower extremities was more than 6, with the largest greater than 11 cm. The lung respiratory sound was coarse, and sputum sound heard. The family history of the newborn was normal, except that her father suffered from CALMs.
CT showed a large mass occupying in the maxillofacial and cervical region that compressed the airway, involving the left cavernous sinus and locally encircling the optic nerve (Fig. 2A-C). CT suspected neurofibromatosis. MRI also showed an enormous irregular mass in the left maxillofacial and cervical region with unclear borders, encasing the left carotid sheath, oppressing the airway, involving the left parotid gland, the left cavernous sinus, and extending into the left orbit (Fig. 2D, E). Contrast enhanced MRI revealed a more homogeneous enhancement of the mass as a whole, with some nodular and mass-like enhancement (Fig. 2F). For these, the MRI diagnosis was suspected neurogenic tumor or Kaposi’s hemangioendothelioma.
The ultrasound showed a large irregular and substantial hypoechoic mass in the deep facial space besides the left cervical spine, around 6.6 × 6.0 × 5.5 cm. The lower edge of the mass was equal to the level of the thyroid gland, the inner upper edge reached the level of the skull base, and the upper edge had unclear boundaries with the submandibular gland and parotid gland. Echo within the mass was uneven. The mass wrapped around the entire extracranial segment of the internal carotid artery to the cranial base level, external carotid artery and branches. The jugular veins were compressed to become narrow. Color Doppler ultrasound revealed dotted blood flow signals within the mass. Contrast-enhanced ultrasound displayed rapid hyperenhancement with slow contouring within the mass, without obvious non-enhancement areas (Fig. 3A-D). Ultrasound diagnosis showed large substantial space occupying lesions on the left cervical and maxillofacial region, and thus neurofibromatosis was considered.
Due to the compression of the trachea by the cervical mass, the child was urgently intubated and ventilated with a ventilator. After 2 days of observation, ultrasound-guided puncture of the mass was performed (Fig. 3E). The pathological findings of the swelling puncture biopsy (hematoxylin-eosin staining) showed that the puncture tissue consisted mainly of spindle cells. The nuclei were oval or short spindle-shaped, with inconspicuous heterogeneity, and no obvious nuclear division was seen. The cytoplasm of the cells was lightly stained or lightly pink stained (Fig. 3F). Immunohistochemical analysis of tumor cells showed S-100 protein (+) and CD34 (+). Histologic examinations were consistent with neurofibromatosis. In light of the child’s medical history, NF1 was suspected. Then whole exome genetic test was conducted on her parents and the child. The results showed a heterozygous variant in their NF1 gene with the mutation locus c.2540T > C (p.L847P), which is a pathogenic mutation. As no mutation at this locus was found in either of her parent, this was a spontaneous germline mutation. Given the extent of the lesion and the low tolerability of the neonate, the possibility of complete surgical resection was low and the risk was high, so the child received conservative treatment temporarily. The child was discharged for family reasons and treated outside hospital, where he survived 6 months, and the family refused to provide treatment details.

Discussion and conclusions

NF1 refers to germline mutation of the NF1 gene originating from chromosome 17q11.2. The mutation can be de novo or familial, characterized by autosomal dominant inheritance. Approximately 50% of NF1 patients are spontaneously mutated [4]. This has no family history of NF1 and is a spontaneous mutation. CALMs are early clinical features of NF1 [5]. According to the uniform diagnostic criteria of National Institutes of Health (NIH) for NF1 in 1988, six or more CALMs are diagnostic [6]. Generally, normal people also carry 1–3 CALMs sometimes, which could explain the coffee milk spots on the father.
In the past 3 decades, there have been few reports on neonatal NF1 (Table 1) [714]. Subcutaneous neurofibroma and plexiform neurofibroma (PNF) are present in 30–50% of NF1 patients. Usually congenitally benign, PNF grows in a reticular pattern to replace normal tissue [15]. PNF can be limited, nodular, or diffuse and seen in the paravertebral region of the trunk (31%), head & neck (31%) and extremities (25%) [5]. Previous ultrasound reports showed that PNF was an irregularly lobulated hypoechoic mass, which ran along the nerve axis on the longitudinal image diagram and displayed target ring sign on the transverse image, with high echo in the center and low echo around. Cystic changes can be seen in about 70% of the masses. However, the Color Doppler flow signals can have many different presentations that have no specificity [16]. The ultrasonography findings in this case were consistent with previous reports. In addition, after the literature review, we found that this case was the first report of using contrast-enhanced ultrasound and ultrasound-guided puncture biopsy to diagnose neurofibromatosis in the left maxillofacial and cervical region. The ultrasound contrast enhancement pattern with quick-in-and-out has been previously reported in a 35-year-old male with non-NF1 pancreatic neurofibroma and a 4-year-old with a giant retroperitoneal neurofibroma [17]. The enhancement pattern in this child was quick in-slow out. The exact cause of such discrepancy could not be demonstrated due to the lack of big data statistics, but this case has accumulated experience for this rare disease.
Table 1
Reports on Neonatal NF1 in the past 30 years
Author
Article Year
Age at diagnosis (d)
Gender
Family history
Presence of CALMs
Location of neurofibroma
Treatment
Berthin C et al. [7]
2019
21d
Male
Unknown
Yes
Eye
Unknown
Sadhukhan M et al. [8]
2017
8d
Female
Unknown
Yes
Retropharyngeal and paraspinal
Taking MEK inhibitors
Day KM, et al. [9]
2020
1d
Female
Unknown
Unknown
Neck
Microlaryngoscopy, bronchoscopy and tracheotomy plus trametinib chemotherapy
Goyal S et al. [10]
2014
6d
Female
Yes
No
Eye
Local excision
Hatanaka K et al. [11]
2013
1d
Male
No
Yes
Posterior mediastinum
Surgery
Colás-Tomás T et al. [12]
2010
1d
Male
Yes
Yes
Posterior ocular
Ahmed glaucoma flap implantation
Stewart H et al. [13]
2008
1d
Female
No
No
Diffuse, most severely involving the head and neck, and the mass found involving almost every tissue at autopsy
Died 42 h after birth
Payne MS et al. [14]
2014
1d
Female
No
None at birth, present at 10w
Paracervical spine
Local excision
PNF usually grows rapidly in early childhood at a volume of ≥ 20% per year [4]. In this case, the mass was large enough to compress the trachea, and thus tracheal intubation was required. This case suggested that the diagnosis of rare diseases should be made with caution and suspicion. Early diagnosis and treatment may improve the long-term prognosis [9].
Neonatal NF1 is rare. Diagnosis is more challenging if it is non-familial inheritance. In this case, the left mass was large enough to compress the airway and surround the blood vessels. Life-threatening conditions such as respiratory and cardiac arrest could occur at any time. Ultrasonic examination, which is convenient and multi-directional, is particularly necessary for early diagnosis. With a high success rate, ultrasound-guided aspiration biopsy has provided a reliable basis for the diagnosis of neurofibromatosis.
Maxillofacial and cervical mass in neonates accompanied by CALMs should consider NF1. The combination use of contrast-enhanced ultrasound and ultrasound-guided puncture biopsy can ensure the diagnosis of this disease.

Acknowledgements

We sincerely appreciate all members of the Department of Ultrasound, Neonatology, and Radiology, Shenzhen Children’s Hospital, Shenzhen, China.

Declarations

The studies involving human participants were reviewed and approved by the Ethics Committee of Shenzhen Children’s Hospital.
The parents of this patient consented to the publication of the case and any accompanying images with written informed consent.

Competing interests

The authors declare no competing interests.
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://​creativecommons.​org/​licenses/​by/​4.​0/​. The Creative Commons Public Domain Dedication waiver (http://​creativecommons.​org/​publicdomain/​zero/​1.​0/​) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Literatur
1.
Zurück zum Zitat Kallionpaa RA, Uusitalo E, Leppavirta J, Poyhonen M, Peltonen S, Peltonen J. Prevalence of neurofibromatosis type 1 in the finnish population. Genet Med. 2018;20(9):1082–6.CrossRefPubMed Kallionpaa RA, Uusitalo E, Leppavirta J, Poyhonen M, Peltonen S, Peltonen J. Prevalence of neurofibromatosis type 1 in the finnish population. Genet Med. 2018;20(9):1082–6.CrossRefPubMed
2.
Zurück zum Zitat He Q, Jiang J, Yang J, Zeng J, Zhang H, Zhang Z. A novel mutation of the NF1 gene in a Chinese family with neurofibromatosis type 1. Am J Transl Res. 2022;14(7):5139–45.PubMedPubMedCentral He Q, Jiang J, Yang J, Zeng J, Zhang H, Zhang Z. A novel mutation of the NF1 gene in a Chinese family with neurofibromatosis type 1. Am J Transl Res. 2022;14(7):5139–45.PubMedPubMedCentral
3.
Zurück zum Zitat Hernandez-Martin A, Duat-Rodriguez A. An update on neurofibromatosis type 1: not just Cafe-au-Lait spots and freckling. Part II. Other skin manifestations characteristic of NF1. NF1 and Cancer. Actas Dermosifiliogr. 2016;107(6):465–73.PubMed Hernandez-Martin A, Duat-Rodriguez A. An update on neurofibromatosis type 1: not just Cafe-au-Lait spots and freckling. Part II. Other skin manifestations characteristic of NF1. NF1 and Cancer. Actas Dermosifiliogr. 2016;107(6):465–73.PubMed
4.
Zurück zum Zitat Blakeley JO, Plotkin SR. Therapeutic advances for the tumors associated with neurofibromatosis type 1, type 2, and schwannomatosis. Neuro Oncol. 2016;18(5):624–38.CrossRefPubMedPubMedCentral Blakeley JO, Plotkin SR. Therapeutic advances for the tumors associated with neurofibromatosis type 1, type 2, and schwannomatosis. Neuro Oncol. 2016;18(5):624–38.CrossRefPubMedPubMedCentral
5.
6.
Zurück zum Zitat National Institutes of Health Consensus Development Conference Statement: neurofibromatosis. Bethesda, Md., USA, July 13–15, 1987. Neurofibromatosis. 1988;1(3):172–178. National Institutes of Health Consensus Development Conference Statement: neurofibromatosis. Bethesda, Md., USA, July 13–15, 1987. Neurofibromatosis. 1988;1(3):172–178.
7.
Zurück zum Zitat Berthin C, Hugny-Larroque C, Heran F, Misery L, Abasq-Thomas C. Image gallery: swelling of the upper eyelid with trichomegaly revealing neurofibromatosis type 1. Br J Dermatol. 2019;181(3):e61.CrossRefPubMed Berthin C, Hugny-Larroque C, Heran F, Misery L, Abasq-Thomas C. Image gallery: swelling of the upper eyelid with trichomegaly revealing neurofibromatosis type 1. Br J Dermatol. 2019;181(3):e61.CrossRefPubMed
8.
Zurück zum Zitat Sadhukhan M, Conry B, Bhaduri B. Extensive retropharyngeal and spinal plexiform neurofibromas in a neonate with type 1-Neurofibromatosis. Indian J Pediatr. 2017;84(8):645–6.CrossRefPubMed Sadhukhan M, Conry B, Bhaduri B. Extensive retropharyngeal and spinal plexiform neurofibromas in a neonate with type 1-Neurofibromatosis. Indian J Pediatr. 2017;84(8):645–6.CrossRefPubMed
9.
Zurück zum Zitat Day KM, Roward S, Gillispie A, Attra J, Kelley P. Early diagnosis and intervention for airway-obstructing neonatal plexiform neurofirbomatosis. J Craniofac Surg. 2020;31(5):e495-7.PubMed Day KM, Roward S, Gillispie A, Attra J, Kelley P. Early diagnosis and intervention for airway-obstructing neonatal plexiform neurofirbomatosis. J Craniofac Surg. 2020;31(5):e495-7.PubMed
10.
Zurück zum Zitat Goyal S, Park A, Zeglam A, Brown H, Pemberton JD. Choroidal Ganglioneuroma and Orbital Plexiform Neurofibroma presenting as Buphthalmos in an infant with neurofibromatosis type 1. Ophthalmic Plast Reconstr Surg. 2016;32(4):e87–89.CrossRefPubMed Goyal S, Park A, Zeglam A, Brown H, Pemberton JD. Choroidal Ganglioneuroma and Orbital Plexiform Neurofibroma presenting as Buphthalmos in an infant with neurofibromatosis type 1. Ophthalmic Plast Reconstr Surg. 2016;32(4):e87–89.CrossRefPubMed
11.
Zurück zum Zitat Hatanaka K, Yoshioka T, Tasaki T, Tanimoto A. Pulmonary rhabdomyomatous dysplasia of the newborn in neurofibromatosis type 1. Pathol Res Pract. 2014;210(5):318–20.CrossRefPubMed Hatanaka K, Yoshioka T, Tasaki T, Tanimoto A. Pulmonary rhabdomyomatous dysplasia of the newborn in neurofibromatosis type 1. Pathol Res Pract. 2014;210(5):318–20.CrossRefPubMed
12.
Zurück zum Zitat Colas-Tomas T, Gutierrez-Diaz E, Tejada-Palacios P, Barcelo-Mendiguchia A, Mencia-Gutierrez E. Management of congenital glaucoma in neurofibromatosis type 1: a report of two cases. Int Ophthalmol. 2010;30(2):211–4.CrossRefPubMed Colas-Tomas T, Gutierrez-Diaz E, Tejada-Palacios P, Barcelo-Mendiguchia A, Mencia-Gutierrez E. Management of congenital glaucoma in neurofibromatosis type 1: a report of two cases. Int Ophthalmol. 2010;30(2):211–4.CrossRefPubMed
13.
Zurück zum Zitat Stewart H, Bowker C, Edees S, Smalley S, Crocker M, Mechan D, Forrester N, Spurlock G, Upadhyaya M. Congenital disseminated neurofibromatosis type 1: a clinical and molecular case report. Am J Med Genet A. 2008;146A(11):1444–52.CrossRefPubMed Stewart H, Bowker C, Edees S, Smalley S, Crocker M, Mechan D, Forrester N, Spurlock G, Upadhyaya M. Congenital disseminated neurofibromatosis type 1: a clinical and molecular case report. Am J Med Genet A. 2008;146A(11):1444–52.CrossRefPubMed
14.
Zurück zum Zitat Payne MS, Nadell JM, Lacassie Y, Tilton AH. Congenital glaucoma and neurofibromatosis in a monozygotic twin: case report and review of the literature. J Child Neurol. 2003;18(7):504–8.CrossRefPubMed Payne MS, Nadell JM, Lacassie Y, Tilton AH. Congenital glaucoma and neurofibromatosis in a monozygotic twin: case report and review of the literature. J Child Neurol. 2003;18(7):504–8.CrossRefPubMed
15.
Zurück zum Zitat Farschtschi S, Mautner VF, McLean ACL, Schulz A, Friedrich RE, Rosahl SK. The Neurofibromatoses. Dtsch Arztebl Int. 2020;117(20):354–60.PubMedPubMedCentral Farschtschi S, Mautner VF, McLean ACL, Schulz A, Friedrich RE, Rosahl SK. The Neurofibromatoses. Dtsch Arztebl Int. 2020;117(20):354–60.PubMedPubMedCentral
16.
Zurück zum Zitat Bouimetarhan L, Bellamlih H, En-Nafaa I, Fenni JE, Amil T, Radouane B. [Plexiform cervical neurofibroma: about a case]. Pan Afr Med J. 2018;30:41.PubMedPubMedCentral Bouimetarhan L, Bellamlih H, En-Nafaa I, Fenni JE, Amil T, Radouane B. [Plexiform cervical neurofibroma: about a case]. Pan Afr Med J. 2018;30:41.PubMedPubMedCentral
17.
Zurück zum Zitat Song L, Jiang Z, Cui J, Gao B, Luo Y. Benign pancreatic neurofibroma with malignant imaging features: a case report and literature review. Front Surg. 2022;9: 874006.CrossRefPubMedPubMedCentral Song L, Jiang Z, Cui J, Gao B, Luo Y. Benign pancreatic neurofibroma with malignant imaging features: a case report and literature review. Front Surg. 2022;9: 874006.CrossRefPubMedPubMedCentral
Metadaten
Titel
Diagnosis of neonatal neurofibromatosis type 1: a case report and review of the literature
verfasst von
Qiuying Zheng
Bei Xia
Xiaoli Zhao
Ruijie Wang
Fusui Xie
Nihui Pei
Hongwei Tao
Tingting Ding
Lei Liu
Publikationsdatum
01.12.2023
Verlag
BioMed Central
Erschienen in
BMC Pediatrics / Ausgabe 1/2023
Elektronische ISSN: 1471-2431
DOI
https://doi.org/10.1186/s12887-023-04077-z

Weitere Artikel der Ausgabe 1/2023

BMC Pediatrics 1/2023 Zur Ausgabe

Ähnliche Überlebensraten nach Reanimation während des Transports bzw. vor Ort

29.05.2024 Reanimation im Kindesalter Nachrichten

Laut einer Studie aus den USA und Kanada scheint es bei der Reanimation von Kindern außerhalb einer Klinik keinen Unterschied für das Überleben zu machen, ob die Wiederbelebungsmaßnahmen während des Transports in die Klinik stattfinden oder vor Ort ausgeführt werden. Jedoch gibt es dabei einige Einschränkungen und eine wichtige Ausnahme.

Alter der Mutter beeinflusst Risiko für kongenitale Anomalie

28.05.2024 Kinder- und Jugendgynäkologie Nachrichten

Welchen Einfluss das Alter ihrer Mutter auf das Risiko hat, dass Kinder mit nicht chromosomal bedingter Malformation zur Welt kommen, hat eine ungarische Studie untersucht. Sie zeigt: Nicht nur fortgeschrittenes Alter ist riskant.

Begünstigt Bettruhe der Mutter doch das fetale Wachstum?

Ob ungeborene Kinder, die kleiner als die meisten Gleichaltrigen sind, schneller wachsen, wenn die Mutter sich mehr ausruht, wird diskutiert. Die Ergebnisse einer US-Studie sprechen dafür.

Bei Amblyopie früher abkleben als bisher empfohlen?

22.05.2024 Fehlsichtigkeit Nachrichten

Bei Amblyopie ist das frühzeitige Abkleben des kontralateralen Auges in den meisten Fällen wohl effektiver als der Therapiestandard mit zunächst mehrmonatigem Brilletragen.

Update Pädiatrie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.